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Genetically engineered fusion proteins offer potential as multifunctional biomaterials for medical use.
Fusion or chimeric proteins can be formed using recombinant DNA technology by combining nucleotide
sequences encoding different peptides or proteins that are otherwise not found together in nature. In the
present study, three new fusion proteins were designed, cloned and expressed and assessed for function,
by combining the consensus sequence of dragline spider silk with three different antimicrobial peptides.
The human antimicrobial peptides human neutrophil defensin 2 (HNP-2), human neutrophil defensins 4
(HNP-4) and hepcidin were fused to spider silk through bioengineering. The spider silk domain main-
tained its self-assembly features, a key aspect of these new polymeric protein biomaterials, allowing the
formation of b-sheets to lock in structures via physical interactions without the need for chemical cross-
linking. These new functional silk proteins were assessed for antimicrobial activity against Gram e
Escherichia coli and Gram þ Staphylococcus aureus and microbicidal activity was demonstrated. Dynamic
light scattering was used to assess protein aggregation to clarify the antimicrobial patterns observed.
Attenuated-total reﬂectance Fourier transform infrared spectroscopy (ATR-FTIR) and circular dichroism
(CD) were used to assess the secondary structure of the new recombinant proteins. In vitro cell studies
with a human osteosarcoma cell line (SaOs-2) demonstrated the compatibility of these new proteins
with mammalian cells.
 2011 Elsevier Ltd. All rights reserved.1. Introduction
Around 350 billion dollars are spent worldwide on organ
replacement therapies to prolong the lives of more than 20 million
patients. Most organ replacement surgeries rely on the use of
organometallic devices, most of whichwere developed in the 1960s
[1,2]. Tissue engineering is an emerging interdisciplinary ﬁeld
focused on the development of tissues and organs that can be used
to replace damaged and failing tissues and organs. One of the major
goals of tissue engineering is to replace permanent implanted
prostheses with temporary implants with reconstructive and
regenerative characteristics capable of directing the full restoration
of normal tissue structure and function in the body; thus they mustaterials, Biodegradables and
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All rights reserved.be fully degradable over time [3]. Achieving this goal would revo-
lutionize healthcare treatment as well as patient well being [4]. The
biomaterials ﬁeld contributes directly toward this goal through the
development of polymers with diverse mechanical and biological
characteristics [5e8] that can be used to facilitate the regeneration
of damaged tissues. In the case of bone repair, meeting mechanical
and functional requirements at the implant site remains a challenge
for most polymeric biomaterials [9,10].
In the present work, spider silk was selected for the core poly-
mer due to its potential as a biomaterial to meet the requirements
for both mechanical stability and biocompatibility necessary for
bone tissue engineering, as well as its accessibility to bioengi-
neering [11e13]. Furthermore, recombinant DNA technologies
allow the generation of spider silk proteins fused to other protein
domains not normally found in spider silks, thereby expanding the
function of these protein polymers. These new chimeric or
multifunctional spider silk-like molecules combine the properties
of silk (e.g., self-assembly, robust material properties and physical
cross-linking to stabilize materials) with characteristics of the new
domains added to the silk. These types of new multifunctional
polymeric biomaterials provide a new route to control biomaterial
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actions. The addition of antimicrobial peptides to reduce or control
infections at the site of implantationwas the direction sought in the
present study.
There are more than 600 peptides known with antimicrobial
activity, most with broad activity against different microorganisms,
including Gramþ and Gram- bacteria, virus, protozoa and fungi
[14]. The bactericidal activity of these molecules starts with direct
binding to the lipid bilayer forming the bacteria membrane. After
this interaction with the membrane the bactericidal peptides
acquire an amphiphilic three-dimensional conformation where the
positive side of the antimicrobial molecules interact directly with
the negatively charged lipid head-groups. This interaction results
in the formation of pores through the bacterial membrane [15,16].
A prominent feature of defensins is the six cysteine residues which
form three disulphide bonds. Cysteine residues confer cationic
nature to defensins and the initial association between these
peptides and bacteria occurs through electrostatic interactions
between the cationic peptides and the negatively charged lipid
forming the outermembrane [17]. Moreover, these peptides play an
important role in inﬂammation [18], and chemotaxis for monocytes
and T cells to activate the acquired immune response system [19].
These peptides also intervene in the wound healing [20] by stim-
ulating the proliferation of ﬁbroblasts and epithelial cells [21,22],
induce neovasculogenesis [23] and mobilize cytokines [24]. Human
a-defensins are cationic cysteine-rich peptides containing between
29 and 35 amino acids [25,26]. Six a-defensins have been described,
human neutrophil defensins 1 to 4 (HNP-1, HNP-2, HNP-3 and
HNP-4) [27], which are expressed in neutrophils, and human
defensins 5 to 6 (HD-5 and HD-6) expressed by Paneth cells of the
small intestine and by the epithelial cells of the female urogenital
track [28]. HNP-2 manifests bactericidal activity against both
Gramþ and Gram- bacteria [29]. HNP-4 was considered more
effective against Gram- Escherichia coli and Enterobacter aerogenes.
Moreover, HNP-4wasmore effective than HNP-1, HNP-2 and HNP-3
in protecting human peripheral blood mononuclear cells from
infection by both X4 and R5 HIV-1 strains [30].
Resembling the human neutrophil defensins described above,
hepcidin (also named LEAP-1 for liver expressed antimicrobial
peptide), is also a cysteine-rich peptide. Hepcidin mRNAwas found
primarily in the liver and was isolated initially from human blood
[31] and later detected in urine [32].Hepcidin exhibits bactericidal
and fungicidal activity with activity against Gramþ and Gram-
bacteria. Hepcidin was active against the Gram- E. coli ML35 strain
and Neisseria cinerea, and against the Gramþ Staphylococcus aureus,
Staphylococcus epidermis, Staphylococcus carnosus, Bacillus cereus,
Bacillus megaterium, Bacillus subtilis,Micrococcus luteus and group B
Streptococcus [31e35]. After incubation of K562 cells (American-
Type Culture Collection leukemic cell line CCL-243) for 15 h with
hepcidin at a concentration of 30 mM, viability of 74%was found [32].
Thus the cytotoxicity of hepcidin was much lower than after incu-
bation of these cells with 30 mM a-defensin HNP-1, where only 9% of
the cells were viable over the same time frame [32]. Based on the
antimicrobial activities of HNP-2, HNP-4 and hepcidin, these
peptides were selected for fusion with the silk protein major
ampullate spidroin protein (MaSpI) in the present study. The silk
was selected as themainprotein component as it has been shown to
self-assemble into impressively strong and tough protein-based
biomaterials, is biodegradable due to the activity of proteases, and
can be formed into a range ofmaterial formats usingwater [36e38].
Due to the relatively low cytotoxicity, resistance to microor-
ganism adaptation and broad spectra of action some antimicrobial
peptides are considered strong candidates to be used in coatings of
polymeric surfaces to help preventing microbial contamination.
However, few studies have addressed this topic. In the past fewyears different antimicrobial peptides were expressed together
with a carbohydrate binding module from Clostridium thermo-
cellum, to enable attachment to different cellulosic surfaces for
antimicrobial properties [39,40]. The chemical coupling of antimi-
crobial peptides to different types of surfaces, such as: polyamide
resins [41], polystyrene-polyethylene glycol beads [42e44] and
titanium [45], has also been reported. To our knowledge this is the
ﬁrst study describing fusion proteins combining both silk and
antimicrobial domains.
The goal of the present study was to construct three new fusion
proteins combining spider silk with antimicrobial features hepci-
din, HNP-2 and HNP-4 (Fig. 1A). Three different antimicrobial
peptideswere selected due to the possible decrease in activitywhen
the peptides were coupled with the spider silk. In this way, the
activities of the three different fusionproteins could be compared to
identify the most useful sequence for biomaterials formation and
characterization. The silk domain in the proteins carries six repeats
of the consensus repeat for the native sequence of the proteinmajor
ampullate dragline silk I (MaSpI) from the spider Nephila clavipes.
Each silk repeat is formed by a hydrophilic GGX motif and
a hydrophobic poly-A motif (Fig. 1B).The three different silk-anti-
microbial fusionswere successfully expressed and characterized for
structure and function. The antibacterial activity was studied by
radial diffusion. Secondary structure of the recombinant proteins
was assessed by attenuated-total reﬂectance Fourier transform
infrared spectroscopy (ATR-FTIR) and circular dichroism (CD).
Dynamic light scattering (DLS) was used to assess aggregation
related to antimicrobial activity in solution. Finally, cytotoxicity
tests were performed to conﬁrm the potential utility of these new
multifunctional silk proteins in contact with mammalian cells.
2. Materials and methods
2.1. Cloning HNP-2, HNP-4 and hepcidin into pET30L vector containing silk modules
Vector pET30aþ (Novagen, San Diego CA) was used for the construction of the
vector pET30L carrying the silk block copolymer using procedures described in our
previous work [46].The silk block copolymer carries six repeats of the consensus
repeat for the native sequence of the proteinmajor ampullate dragline silk I from the
specie N. clavipes. This spider silk block copolymer (6mer) was cloned with six
histidine residues to facilitate proteinpuriﬁcation, andwith two restriction sites, one
for SpeI and another NheI, ﬂanking its edges to allow the addition of other DNA [46].
The HNP-2, HPN-4 and hepcidin cDNA sequences were prepared through the
annealing of synthetic single strand oligonucleotide sequences (Invitrogen, CA,
USA): HNP-2 top and HNP-2 bottom, HNP-4 top and HNP-4 bottom and hepcidin top
and hepcidin bottom. The annealing reactions were carried out by decreasing the
temperature of the oligonucleotide solution from 95 C to 20 C with a gradient of
0.1 C/s. The presence of the annealed products was veriﬁed with 5% agarose gels. At
the edges of each cDNA sequence restriction sites were present for SpeI and for NheI
for the insertion of the cDNA sequences into the vector pET30L. This vector already
carried the DNA encoding the silk block copolymer. For the insertion of the cDNA
sequences into pET30L, the vector was digestedwith SpeI (NewEngland Biolabs, MA,
USA, R0133S), dephosphorylated with calf intestinal phosphatase (CIP) (New
England Biolabs, M0290S) and run on 0.8% agarose gels. The linearized vector was
puriﬁed using the QIAquick gel extraction kit (Qiagen, CA, USA, 28706). The cDNA
sequences were double digested with SpeI and NheI and the digestion products run
in a 0.8% gel and the bands for the cDNA sequences were puriﬁed using a QIAquick
gel extraction kit. HNP-2, HPN-4 and hepcidin cDNAwere ligated individually to the
silk 6mer present in the expression vector pET30L using T4 DNA ligase enzyme (New
England Biolabs, M0202S).
E. coli DH5a cells (Invitrogen, 18258e012) were transformed with the ligation
products and successful transformants were identiﬁed by plating on agar plates
containing 25 mg/mL kanamycin. The presence of the HNP-2, HPN-4 and hepcidin
inserts was conﬁrmed by DNA sequencing (Tufts Core Facility, Boston, MA) using T7
primers and the new constructs were named: 6merþHNP-2, 6merþHNP-4 and
6mer þ hepcidin.
2.2. Protein expression and puriﬁcation
The 6mer, 6merþHNP-2, 6merþHNP-4 and 6mer þ hepcidin were expressed in
E. coli RY-3041 strain, a mutant strain of E. coli BLR(DE3) defective in the expression
of SlyD protein [46,47]. SlyD protein was reported in previous studies as co-eluting
Fig. 1. (A) Amino acid sequences for the chimeric proteins carrying silk block copolymer (6mer) and the HNP-2 (a), HNP-4 (b) and the hepcidin (c) peptide sequences. The 6mer
block is represented by black. The HNP-2 (a), HNP-4 (b) and hepcidin (c) sequences are represented by a gray. The restriction sites for the insertion of HNP-2, HNP-4 and hepcidin
sequences are underlined. (B) Amino acid sequences for the hydrophobic and hydrophilic blocks present in each of the six units forming the silk block copolymer (6mer).
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histidine content, an amino acid with known afﬁnity for Ni-NTA columns. In E. coli
RY-3041 strain the C-terminus, with the high content of histidines, of the SlyD
protein was deleted to avoid co-elution with expressed recombinant proteins with
his fusion tags [47]. Cells were cultivated at 37 C in LB medium, with 25 mg/mL
kanamycin until an OD600 between 0.9 and 1 was reached. At this point expression
was induced with isopropyl b-D-thiogalactoside (IPTG, Invitrogen, 15529019) to
a ﬁnal concentration of 0.5 mM. After 2 h of expression the cells were harvested by
centrifugation at 6500 rpm. The cell pellet was resuspended in denaturating buffer
(100 mM NaH2PO4, 10 mM Tris HCl, 8 M urea, pH 8.0) and left overnight with stirring
for complete cell lysis. Insoluble cell fragments and soluble proteins present in the
cell lysate were separated through centrifugation at 11000 rpm. The supernatant
was mixed with Ni-NTA resin (Qiagen, 30250) and left for 2 h with stirring. The
supernatant/Ni-NTA resin mixture was loaded onto a glass Econo-column (Biorad)
and washed several times with denaturating buffer at pH 8.0 and then pH 6.0. The
6merþHNP-2, 6merþHNP-4 and 6mer þ hepcidin proteins were eluted using
denaturating buffer at pH 4.5. The puriﬁed proteins were dialyzed ﬁrst in a 20 mM
sodium acetate buffer followed by extensive dialysis in MQ water using cellulose
ester snake skin membranes with a 100e500 Da molecular weight cut off (Spectra/
Por Biotech, 131054). The dialyzed proteins were lyophilized in a LabConco lyophi-
lizer. Protein sequencing (Tufts Core Facility, Boston, MA), SDS-PAGE and western
blot were used to conﬁrm protein identity.2.3. Protein identiﬁcation by western blot
Proteins were mixed with NuPAGE LDS sample buffer (Invitrogen, NP0007) and
heated to 80 C for 10 min.The samples were separated using a Bis-tris 4e12% gel
(Invitrogen, NP0321BOX). For the western blot the His-Tag AP western kit provided
by Novagen, EMD Biosciences, NJ, USA (70972) was used with the protocol provided.
Brieﬂy, bands were electro-transferred onto a nitrocellulose membrane at 30V for
16 h. Membranes were blocked for 1 h with 3% bovine serum albumin (BSA) in TBS
buffer (blocking solution). After washing with tris buffered solution (TBS buffer) the
membrane was incubated for 1 h with mouse anti-histidine monoclonal antibody
(Novagen) diluted 1:1000 in blocking solution. Following proper washing with
TBSTT buffer (TBS with tween 20) the membrane was incubated for 1 h with goat
anti-mouse IgG AP conjugated antibody diluted 1:5000 in blocking solution.Colorimetric detection was performed with developing solution of 5-bromo-4-
chloro-3-indolylphosphate (BCIP) and nitrobluetetrazolium (NBT).
2.4. Film formation and ATR-FTIR secondary structure analysis
Recombinant 6merþHNP-2, 6merþHNP-4, 6mer þ hepcidin and 6mer proteins
were dissolved in MQ water to a ﬁnal concentration of 2% (w/v).Then 60 ml of each
protein solution was cast onto a non adherent polystyrene surface and left to dry at
room temperature. The ﬁlms obtained were treated with 70% methanol for 2 h to
induce the transition of secondary structure from random coil to b-sheet. This
treatment produced ﬁlms with improved mechanical properties and more resistant
to dissolution in water or other aqueous environments such as culture media. For
cell studies the ﬁlms were treated with 70% (w/w) ethanol solution for sterilization
purposes. ATR-FTIR (Jasco Inc., MD, USA, model FT/IR-6200) was performed before
and aftermethanol treatment of the ﬁlms to investigate secondary structure. Spectra
were collected in absorption mode at 8 cm1 resolution and a 4000 to 400 cm1
regionwas scanned. The quantiﬁcation of the secondary structure was based on the
analysis of the amide I and amide II regions (1700e1450 cm1). The average
percentage for the secondary structures, mainly b-sheet content for the 6mer
(control situation), 6merþHNP-2, 6merþHNP-4 and 6mer þ hepcidin proteins was
calculated through the integration of the area of each deconvoluted curve followed
by the normalization of the obtained value to the total area of the amide I and amide
II regions [48]. OPUS deconvolution software (Bruker optics, Billerica, MA, USA) was
used for spectrum deconvolution and each deconvoluted spectrumwas curve-ﬁtted
with Gaussian bands using the peak pick function. After curve-ﬁtting information
concerning the percentage of amide I and II regions, bandwidth and band position,
referring to b-sheet or a-helix conformations, was obtained [49].
2.5. Antibacterial assay
The puriﬁed recombinant proteins were tested for antimicrobial activity against
E. coli (American-Type Culture Collection ATCC 25922, VA, USA,) and S. aureus (ATCC
25923), purchased from American-Type Culture Collection. The radial diffusion
assay [50] was used to test three concentrations of the puriﬁed proteins dissolved in
phosphate buffer (pH 7.4): 10, 50 and 100 mg/mL. The 6mer protein solutions were
used as controls. E. coli and S. aureus lawns were plated on LB-agar plates, using
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diameter was use to cut circles from ﬁlter paper (Whatman, Piscataway, NJ, USA,
09-845B) that were used as blank susceptibility disks. For sterilization, the disks
were immersed in a 70% (v/v) ethanol solution for 1 h and left to dry for 2 h in
a hood. After drying, the discs were immersed in the different protein solutions,
placed on the bacterial lawns and incubated overnight at 37 C. The zones of growth
inhibition formed around the susceptibility disks were measured using Image J
software. The 6mer protein was used as a negative control in order to exclude the
effect from silk itself and from possible contaminants derived from the expression
and puriﬁcation processes. Experiments were carried out in triplicate.
2.6. Aggregation
A Zetasizer NanoZS instrument (ZEN3600, MALVERN Instruments, Worcester-
shire, UK) was used for DLS measurements. DLS was performed on solutions at the
same concentrations used for the antibacterial assay (section 2.5): 10, 50 and
100 mg/mL. Samples were prepared with phosphate buffer (pH 7.4). The scattering
light was collected at a 173 scattering angle.
2.7. Circular dichroism spectroscopy
Circular Dichroism (CD) spectroscopy was performed on an Aviv, Model 410
(Biomedical, Inc. NJ USA) instrument. The spectra were collected between 260 and
180 nm with a step size of 1 nm, an averaging time of 1s and ﬁve scans were
collected for each sample. A baseline spectrum was subtracted from the samples.
Sample cells with a 0.1 cm path length were used and measurements were per-
formed with 1 mg/mL protein solutions in phosphate buffer (pH 7.4).
2.8. Cytotoxicity assay
Human osteosarcoma cell line (SaOs-2) is an immortalized cell line with oste-
oblastic phenotype (HTB-85) and was purchased from the American-Type Culture
Collection. Cells were cultured using basal medium consisting in Dulbecco’s
modiﬁed Eagle’s medium (DMEM) supplemented with 10% (v/v) fetal bovine serum
(FBS), 1% penicillin-streptomycin (v/v), at 37 C with 5% CO2 in a humidiﬁed envi-
ronment. After reaching conﬂuence, cells were harvested with trypsin/EDTA and
after counting cells they were seeded at 3.0103 cells/cm2 in a 96 well plate coated
with the four different types of protein ﬁlms, 6merþHNP-2, 6merþHNP-4,
6mer þ hepcidin, 6mer (control) ﬁlms, prepared as in section 2.3. Tissue culture
plate (TCP) was used as a positive control in this assay. The Alamar blue (Invitrogen,
DAL1025) assay was used to determine cell viability/proliferation after three days of
culture. Alamar Blue reagent was added to the growth media in a 1:10 dilution ratio
and data was collected using ﬂuorescence at 530e560 nm excitation and 590 nm
emission [51]. A standard curve with the different cell numbers (10,000, 5000, 2500
and 0) on the x axis and the corresponding ﬂuorescence values on the y axis were
used to determine the cell numbers as detailed by the supplier.
2.9. Statistical analysis
SPSS 17.0 was used to perform statistical analysis. The ShapiroeWilk test was
use to test for the normality of the data. To test for signiﬁcant differences between
different experimental groups (6merþHNP-2, 6merþHNP-4, 6mer þ hepcidin,
6mer) one-way ANOVAwith a Dunet’s T3 post hoc comparison was used. Statistical
signiﬁcance was deﬁned as p < 0.05.
3. Results
3.1. Cloning and expression of HNP-2, HNP-4 and hepcidin
The presence of the HNP-2, HNP-4 and hepcidin inserts in the
cloning vector containing the silk modules was conﬁrmed through
DNA sequencing (Tufts Core Facility, Boston, MA). SDS-PAGE and
Western blots (Fig. 2) indicated that both expression and puriﬁca-
tion of 6mer (control), 6merþHNP-2, 6merþHNP-4 and
6merþ hepcidin proteins was successful and protein sequencing at
Tufts Core Facility, Boston, MA conﬁrmed the N-terminal amino
acid sequence for the all three proteins. For 6merþHNP-2,
6merþHNP-4, 6mer þ hepcidin and 6mer proteins the theoretical
molecular weights were approximately 24.6, 25, 24.1 and 21.8 kDa,
respectively, and with SDS-PAGE and Western blot assays bands
were observed at around 28 kDa (Fig. 2). Furthermore, with SDS-
PAGE and Western blot the presence of dimers and multimers
corresponding to aggregation products of the monomer forms
were also observed, together with pre-terminated sequencesrepresenting proteins whose expression was incomplete and
therefore present a lower molecular weight than the monomeric
complete proteins. After puriﬁcation, dialysis and lyophilization the
yield of 6merþHNP-2, 6merþHNP-4, 6mer þ hepcidin were
approximately 12 mg/L for each of the proteins, and for the 6mer
control protein the yield was 25 mg/L.
3.2. Film formation and secondary structure analysis
The ATR-FTIR spectra for the 6mer (control), 6merþHNP-2,
6merþHNP-4 and 6mer þ hepcidin ﬁlms, before and after meth-
anol treatment, exhibited strong amide I (1700-1600 cm1) and
amide II (1600-1500 cm1) regions (Fig. 3). Before methanol
treatment the ATR-FTIR spectra for 6merþHNP-2, 6merþHNP-4,
6mer þ hepcidin and 6mer protein ﬁlms exhibited vibrational
modes in the range of 1650-1647 cm1, amide I region, indicative of
helix/random coil conformations. After methanol treatment two
peaks appeared, one in the range of 1620e1630 cm1, amide I
region, and another in the range of 1510e1530 cm1, amide II
region. Both peaks were indicative of antiparallel b-sheet structures
[46,52,53]. Spectra deconvolution revealed the percentage of helix/
random coil conformations and of antiparallel b-sheet structures
for the 6merþHNP-2, 6merþHNP-4, 6mer þ hepcidin and for 6mer
ﬁlms before and after methanol treatment (Fig. 3). For all four ﬁlms
an increase of b-sheet content was observed with a corresponding
decrease in the helix/random coil conformation after methanol
treatment (Fig. 3). The b-sheet content after methanol treatment
was similar for all four constructs ranging between 39.8% for
6merþHNP-2 and 42.8% for 6merþHNP-4. For the 6mer and the
6mer þ hepcidin ﬁlms the content was 40.8% and 41.9%,
respectively.
3.3. Antimicrobial activity of 6merþHNP-2, 6merþHNP-4 and
6mer þ hepcidin proteins
The antimicrobial activity of 6merþHNP-2, 6merþHNP-4 and
6mer þ hepcidin against the Gram- E. coli and the Gramþ S. aureus
was studied using the radial diffusion assay. The three proteins
displayed antimicrobial activity against E. coliwith the formation of
inhibition zones at all three concentrations tested (Figs. 4 and 5). In
the case of E. coli, 6merþHNP-4 and 6mer þ hepcidin registered
higher bactericidal values when compared with the 6merþHNP-2
peptide. For all three proteins the highest antimicrobial activity was
at a concentration of 10 mg/mL (p < 0.05). Against S. aureus there
was a decrease in bactericidal activity for all the three peptides
when compared to E. coli, based on the smaller diameter inhibition
zone, especially in the case of the 6merþ hepcidin and 6merþHNP-
2 (Fig. 5). For the proteins tested there was a decrease in the
bactericidal activity from 10 to 100 mg/mL (p < 0.05). The 6mer
proteinwas used as a negative control and no inhibition zones were
detected for the three concentrations tested (Fig. 5).
3.4. Aggregation
For the 6mer, 6merþHNP-2, 6merþHNP-4 and 6merþ hepcidin,
DLS measurements detected an increase in particle diameter with
increasing protein concentration, indicating that aggregation was
dependent on protein concentration (Fig. 6). In the case of the 6mer,
only one peak was detected for each of the three concentrations
measured. In contrast, for 6merþHNP-2, 6merþHNP-4 and
6mer þ hepcidin two peaks were always detected, except for
6mer þ hepcidin at concentration of 100 mg/mL. These data indi-
cated the coexistence of smaller (between 24 and 44 nm) and larger
(between 110 and 238 nm) aggregates, the size of which decreased
with decreasing protein concentration.
Fig. 2. SDS-PAGE gel stained with colloidal blue (A) and western blot using anti-histidine antibody (B). 1 - 6mer, 2 - 6mer þ hepcidin, 3 - 6merþHNP-2 and 4 - 6merþHNP-4. (For
interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article).
S.C. Gomes et al. / Biomaterials 32 (2011) 4255e4266 42593.5. Circular dichroism spectroscopy
CD spectroscopy was carried out for the four recombinant
proteins, 6merþHNP-2, 6merþHNP-4, 6mer þ hepcidin and 6mer,
in phosphate buffer (pH 7.4). The spectra of the 6mer indicated
a dominant b-hairpin conformation characterized by a negative
ellipticity with a minimum at approximately 203 nm (Fig. 7). In the
case of 6merþHNP-2, 6merþHNP-4 and 6mer þ hepcidin
the spectra suggested the presence of both b and a conformations
with two minima at 204e208 and 220 nm [54e57].
3.6. Cytotoxicity
Cell viability/proliferation with the SaOs-2 cells was measured
after 3 days of culture using the Alamar Blue assay. The results
indicated that therewere no signiﬁcant differences (p< 0.05) in cell
viability/proliferation between cells cultured on 6merþHNP-2,
6merþHNP-4, 6mer þ hepcidin and 6mer ﬁlms. Furthermore,
when cell viability/proliferation results (expressed in cell number)
for 6merþHNP-2, 6merþHNP-4 and 6mer þ hepcidin ﬁlms were
compared with the results for the positive control TCP, only the
6merþHNP-4 ﬁlms had a cell number signiﬁcantly lower than TCP,
p < 0.05 (Fig. 8).
4. Discussion
The design and successful expression of three new chimeric
proteins is presented through the fusion of the consensus repeat for
spider silk protein MaSp1 (6mer) with hepcidin, HNP-2 and HNP-4
(Fig. 1). SDS-PAGE andWestern blots showed the presence of bands
around 28 kDa (Fig. 2). The difference between the expected and
the observed molecular weights for 6merþHNP-2 (24.6 kDa),
6merþHNP-4 (25 kDa) and 6mer þ hepcidin (24.1 kDa) proteins is
probably due to the formation of cysteine bridges which interfere
with the migration of the proteins during electrophoresis and also
lead to the formation of multimers. This behavior was also detectedfor other proteins such as bone morphogenetic proteins with six
cysteine residues involved in the formation of intra and inter-
molecular disulphide bonds [58,59]. Furthermore, additional DLS
measurements with silk proteins in SDS solution showed the
formation of aggregates (data not shown) which can also interfere
with the migration of these proteins during electrophoresis and
lead to the formation of higher molecular weight structures as well
as multimers.
ATR-FTIRwas used to conﬁrm the integrity of the 6mer sequence
in the three proteins (Fig. 3). The spectra collected for the three new
proteins ﬁlms, 6merþHNP-2, 6merþHNP-4 and 6mer þ hepcidin,
demonstrated the presence of b-sheet, with peaks in
1620e1630 cm1 for amide I region and 1510e1530 cm1 for amide
II region [46,52,53], aftermethanol treatment. Furthermore, spectral
deconvolution indicated an increase of b-sheet content for
6merþHNP-2, 6merþHNP-4 and 6mer þ hepcidin, after methanol
treatment, reaching values similar to those obtained for the 6mer
control (Fig. 3); with 39.8% for 6merþHNP-2, 40.8% for the 6mer,
42.8% for 6merþHNP-4 and 41.9% in the case of 6mer þ hepcidin.
These data demonstrate that the core self-assembling spider silk
domain retained function related to the generation of b-sheet
crystals in these new fusion systems. This is important for the
material performance of these new proteins to attain self-standing
material formats, such as the ﬁlms studied here.
The three new fusion proteins, 6merþHNP-2, 6merþHNP-4,
6mer þ hepcidin, also retained antimicrobial activity attributed to
the inserted motifs HNP-2, HNP-4 and hepcidin, respectively
(Figs. 4 and 5). Previous studies have demonstrated the efﬁcacy of
HNP-2, HNP-4 and hepcidin against different strains of E. coli [32].
6merþHNP-4 presented the highest antibacterial activity, except
for the concentration 100 mg/mL, whereas 6merþHNP-2 man-
ifested the lowest bactericidal activity. These data support the
functional attributes of the antimicrobial component of the fusion
proteins, the second critical component of the protein polymer
designs, to add to the silk material properties above. Additionally,
besides testing the concentrations of 10, 50 and 100 mg/mL other
Fig. 3. ATR-FTIR spectra of 6mer, 6merþHNP-2, 6merþHNP-4, 6mer þ hepcidin ﬁlms before and after treatment with 70% methanol and respective percentage of b-sheet and
random coil/helix conformations after ATR-FTIR spectra deconvolution.
S.C. Gomes et al. / Biomaterials 32 (2011) 4255e42664260concentrations were also evaluated (data not shown for, 1 and 5 mg/
mL), however the antimicrobial effect was either very reduced or
nonexistent. For this reason the concentration of 10 mg/mL was
selected in the present study as the lower concentration with an
antimicrobial effect.The three proteins had a decrease in their antimicrobial activity
against S. aureuswhen compared to E. coli. This reduction in activity
was also detected previously in the case of hepcidin. Park and co-
workers isolated two different hepcidin peptides, hepcidin 20 and
hepcidin 25, fromhuman urine and tested their bactericidal activity
Fig. 4. Graphics representing the antimicrobial activity of 6merþHNP-2, 6merþHNP-4 and 6mer þ hepcidin using a radial diffusion assay. Recombinant 6merþHNP-2, 6merþHNP-
4, 6mer þ hepcidin proteins were used in concentrations of 10 mg/ml, 50 mg/ml and 100 mg/ml against E. coli and S. aureus. 6mer was used as control. As mentioned in section 3.4 no
inhibitory effect was detected for the 6mer protein and for that reason it was not included in the graphic representation. * stands for p < 0.05.
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peptides were antimicrobial against E. coli ML35p but showed
a reduction in activity against S. aureus [32]. Ericksen and
colleagues [60] studied the activity of different a-defensins (HNP-1,
HNP-2, HNP-3, HNP-4, HD-5 and HD-6) against different bacterial
strains and demonstrated that HNP-4 was the most effective
against Gram- bacterial strains, one of which was E. coli ATCC
25922, the same strain as used in this present study.
Furthermore, in the present work for a concentration of
10 mg/mL the 6mer þ hepcidin was more efﬁcient against S. aureus
than the other two proteins. However, with an increase in the
protein concentration from 10 to 50 mg/mL the 6merþHNP-4
became more effective. For both E. coli and S. aureus 6merþHNP-2
proved to be the less bactericidal. Wilde and colleagues [61]
compared the antimicrobial activities of HNP-4 and a mixture
of HNP-1, HNP-2 and HNP-3 and concluded that HNP-4 was
approximately 100-fold more potent against Gram- E. coli and
about 4-foldmore potent against Gramþ Streptococcus faecalis.This
difference in efﬁcacy may be one of the reasons why human
neutrophils produce HNP-1, HNP-2 and HNP-3 at a 60-fold greater
abundance when compared with the production of HNP-4 [60,62].
These results are similar to those obtained in the present workwhere 6merþHNP-4 had higher antimicrobial activity when
compared with 6merþHNP-2.
Additionally, in order to facilitate the comparison between the
present study and previous studies, using the same antimicrobial
domains, the peptide concentrations studied herewere kept within
the same range of concentrations as those used previously
[34,35,60,61]. However, in the present study and in contrast towhat
was observed in previous reports, the antimicrobial activity of the
new chimeric proteins was not always concentration dependent.
The presence of the 6mer silk domain explains this behavior, since
silk proteins are known to aggregate in solution with increased
concentration. The 6mer protein, similar to the silk ﬁbroin collected
from the silk worm Bombyxmori, is rich in hydrophobic amino acids
having a high percentage of the hydrophobic amino acids alanine
and glycine. The presence of these hydrophobic cores induce the
assembly of 6merþHNP-2, 6merþHNP-4 and 6mer þ hepcidin
proteins toward the more thermodynamically stable assembly
resulting in a structural reorganization with reduction of exposure
of hydrophobic residues [63]. In the case of the silk domains, this
stability is achieved by self-assembly or by aggregation. In the
present studya relationship betweenprotein concentration and size
of the aggregates was found as measured by DLS (Fig. 6). The 6mer
Fig. 5. Images showing the antimicrobial activity of 6merþHNP-2, 6merþHNP-4 and 6mer þ hepcidin using radial diffusion assay. Recombinant 6merþHNP-2, 6merþHNP-4,
6mer þ hepcidin proteins were used at concentrations of 10 mg/ml, 50 mg/ml and 100 mg/ml against E. coli and S. aureus. 6mer was used as control. Discs were 8 mm in diameter.
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mL concentrations with an average of 279 and 670 nm, respectively.
The other three proteins, 6merþHNP-2, 6merþHNP-4 and
6mer þ hepcidin, presented bi-modal distributions of sizes, except
for 6mer þ hepcidin at a concentration of 100 mg/mL. In most cases
the aggregate size generated by these proteins was smaller than in
the case of the 6mer alone. Moreover, the dependence between
protein concentration and aggregates size for 6merþHNP-2,
6merþHNP-4 and 6merþhepcidinwas not as evident as in the case
of the 6mer alone. This fact can be explained by the presence of the
antimicrobial domain which increases the number of charged
amino acid residues resulting in a reduction of the tendency of theseproteins to aggregate by enhancing interactions with the solvent.
A previous study where DLS was applied to the dynamic behavior
and the conformational characteristics of B. mori silk ﬁbroin
demonstrated that this molecule forms large and stable aggregates
even in very dilute solutions, supporting the tendency of silk
molecules to form aggregates even in dilute conditions [64].
In the present work the decrease in antimicrobial activity of the
new chimeric proteins as their concentration in solution increased
canbe explained by the occurrence of aggregation resulting in larger
andmore stable aggregates as protein concentrationwas increased.
This interaction leads to adepletionof proteinmonomers in solution
leaving fewer molecules free in solution to act against the bacteria.
Fig. 5. (continued).
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absence of post-translationalmodiﬁcations leading to the formation
of disulphide bonds between cysteine residues. The results obtained
by Varkey and co-workers with HNP-1 peptides indicate that the
presence of all three disulphide bonds and the order of connectivity
are not essential for maintaining the activity of HNP-1. Also, linear
HNP-1 peptides maintained antibacterial activity, however there
was a 10e20-fold reduction in activity [54].
CD analyses indicated that in aqueous medium 6merþHNP-2,
6merþHNP-4 and 6mer þ hepcidin displayed both b-hairpin and
a conformations. In the case of the 6mer b-hairpin or b-sheet are
the predominant conformations (Fig. 7) [54e57]. Previous CDconformation studies with synthetic HNP-1 in aqueous medium
showed a spectrum with a minimum of 205 nm indicating the
presence of b conformation [57]. b structure was also observed for
HNP-1 peptides with two or three disulphide bonds [57]. These
spectra have a minimum at 215 nm and differ from the ideal b-
sheet spectra due to distortions and structural ﬂexibility [57].
Additionally, a later study also with HNP-1 peptides dissolved in
water showed spectra characteristic of an unordered structure.
However, when these peptides are dissolved in sodium dodecyl
sulphate or triﬂuoroethanol their spectra showed the presence of
both b and a conformations with minimums at 205 and 223 nm
[54], very similar to the spectra obtained for 6merþHNP-2 and
Fig. 6. DLS measures of particle diameter (nm) as a function of protein concentration.
S.C. Gomes et al. / Biomaterials 32 (2011) 4255e426642646merþHNP-4 proteins in the present study. In the case of hepcidin
a previous study showed a CD spectrum for this peptide in phos-
phate buffer (pH 7.4) with b-turns, loops and b-sheet [32]. In the
present study the spectrum for 6merþ hepcidin showed both b and
a conformations.
For quantitative evaluation of the cytotoxic response to the
chimeric proteins, the osteosarcoma cell line SaOs-2 was cultured
on 6merþHNP-2, 6merþHNP-4 and 6mer þ hepcidin ﬁlms. The
6merþHNP-2 and 6mer þ hepcidin 2% ﬁlms showed the sameFig. 7. CD spectra for the recombinant 6merþHNP-2, 6merþHNP-4, 6mer þ hepcidin
and 6mer.ability as TCP to support viable cells (p > 0.05), while the
6merþHNP-4 ﬁlms showed a signiﬁcant difference (p < 0.05) from
TCP (Fig. 8). No signiﬁcant difference was observed between
6merþHNP-2, 6merþHNP-4, 6mer þ hepcidin and 6mer ﬁlms.
These results indicated that these chimeric proteins, when pro-
cessed into ﬁlms, are capable of supporting cell proliferation, and
the bactericidal activity does not impact mammalian cell function.
Many drug delivery systems for antibiotics have been described.
Hydroxyapatite microspheres can be loaded with an antibiotic andFig. 8. Alamar blue for cells cultured on 6merþHNP-2, 6merþHNP-4, 6mer þ hepcidin
and 6mer ﬁlms after three days. TCP stands for tissue culture plastic, used as a positive
control, and * stands for p < 0.05.
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dontitis [65], chronic osteomyelitis [66], as just two examples.
Nonetheless, hydroxyapatite-carrying systems tend to have a initial
burst releasing the entire antibiotic in the ﬁrst hours [65] and in
many cases the antibiotics elute only for a short period of time
[67,68]. This can be problematic if the ﬁnal purpose is to obtain
a more controlled release of the drug through time. In recent
studies, different biopolymers have also been tested for potential
applications as drug delivery systems. Silk ﬁbroin [69,70], collagen
[71,72] and hyaluronic acid [73] are examples of natural polymers
that have been used as a carrier systems for growth factors, such as
bone morphogenetic proteins (BMPs), and antibiotics, in the form
of micro-particles, membranes and scaffolds.
Antibiotic-doped biomaterials can be used to address growing
concerns with the selection and spreading of multiresistant path-
ogens [74]. Antimicrobial peptides, as new chemotherapeutic
molecules due to their activity against different types of microor-
ganisms, are also important options, including antimicrobial
functions as well as immune response [75] and wound repair [20]
impacts. However, due to their peptidic nature these biomolecules
are more susceptible to proteolytic digestion [76]. Therefore, their
combination with a suitable delivery system, such as the one pre-
sented in this work, may represent an advantage by decreasing
proteolitic digestion [77] and by allowing for more controlled
release of these peptides to prolong effectiveness over time. This
more controlled release is important in maintaining regional or
localized effects, more precisely at the interface between the
implant/host tissues, where bacterial colonization and posterior
inﬂammation development ﬁrst take place [74].5. Conclusions
The present study outlines the formation of new silk-based
chimeric proteins with antimicrobial potential. Secondary structure
analysis, performed by ATR-FTIR, indicated that silk maintains
b-sheet formation capability even after adding the antimicrobial
domains, HNP-2, HNP-4 and hepcidin. The maintenance of the
capacity to form b-sheet is important, since these physical cross-
links are responsible for the exceptional mechanical properties,
stability and slow degradability of silk. Moreover, activity tests
against Gram- and Gram þ organisms showed that the antimicro-
bial domains present in 6merþHNP-2, 6merþHNP-4 and
6mer þ hepcidin proteins maintained bactericidal activity. Cyto-
toxicity/proliferation studies demonstrated that the new proteins
were capable of sustaining the proliferation of mammalian cells.
These new chimeric proteins suggest a new multifunctional
approach to generate biomaterials with useful properties, in this
case, control of infections due to the addition of the antimicrobial
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